Gamunex-C IVIg Infusion Therapy
What is Gamunex-C?
Gamunex-C is a biologic, intravenous immunoglobulin (IVIg) drug used to treat primary immunodeficiency (PI) disease in patients 2 years and older, immune thrombocytopenic purpura (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP).
How does Gamunex-C work?
Primary Immunodeficiency
People with PI disease experience frequent and recurring infections because they lack healthy infection-fighting proteins in their blood called antibodies. Gamunex-C contains antibodies derived from healthy human blood, which helps PI patients fight off serious bacterial and viral infections. Studies have shown that patients receiving Gamunex-C had 2 times fewer sinus infections, which is the most common infection experienced by PI patients.
Immune Thrombocytopenic Purpura
Patients with ITP have defective immune systems that make antibodies that destroy blood clotting cells called platelets. Gamunex-C can quickly increase platelet counts to control bleeding.
Chronic inflammatory Demyelinating Polyneuropathy
Gamunex-C provides CIDP patients with healthy antibodies to block the immune and inflammatory processes that attack and destroy the myelin sheath (protective nerve coverings).
How is Gamunex-C administered?
Gamunex-C is administered intravenously once every 3 to 4 weeks. The dose depends on age and body weight. Each infusion lasts approximately 3 hours.
Click here to visit the pharmaceutical website for Gamunex-C.
Gamunex-C PATIENT Assistance PROGRAM
This product may be used to treat other conditions not listed. If you are currently using or have a physician’s order to begin using this product for an unlisted condition and you have questions about whether or not we can offer you infusion services, please call our office or fill out a form and a member of our team will reach out to you as soon as possible.
If you’d like more information about the other treatment options we offer, please visit the IV infusions or biologic injections pages to learn more.